JP2017137279A - Tablet which can be freely divided one by one or a plurality of each in connected state - Google Patents

Abstract

PROBLEM TO BE SOLVED: To solve the problems that a conventional tablet requires high production cost due to a multi-type production even containing a same active ingredient because there are as many kinds as the number of capacity differences, and that though there are also tablets which can be divided in half, it is difficult to divide precisely even using a tool and many tablets can be difficult to be divided with empty hands.SOLUTION: A tablet that can be freely divided one by one or a plurality of each in a connected state is characterized by a point contact in a condition where tablets are stood, or a link in a runner state, or a cross type point contact where tablets are crossed in vertically and horizontally one by one, or a link by using a core, such as agar, in a tablet.SELECTED DRAWING: Figure 1

Description

本発明は、医療品やサプリメントの錠剤に、関するものである。  The present invention relates to tablets for medical products and supplements.

従来、一個の錠剤を、半分等に分割する錠剤は存在した。またパッケージにおいて、一個を仕切りつつ並列状態になった錠剤は、広く使われている。  Conventionally, there is a tablet that divides one tablet into halves. In the package, tablets that are in a parallel state while partitioning one are widely used.

パッケージにおける問題としているのではなく、パッケージされる前の錠剤の裸の状態での、連結及び分割問題として提起するものである。  It is not a problem in packaging, but rather a connection and splitting problem in the bare state of the tablet before packaging.

発明を解決する手段Means for Solving the Invention

パッケージされる前の裸の段階において、一個一個の錠剤の形は様々であっても、一個一個が点接触、又は、ランナー状（細く短い分離帯）で連結されており、又は、錠剤成分そのものではないが、錠剤成分を害しない寒天等の素材で出来た芯を錠剤に貫通させた芯入り連結の形になっている。
以上を特徴とする連結状態で一個ずつ又は複数個ずつ自由に分割できる錠剤である。Even if the shape of each tablet is various in the naked stage before packaging, each tablet is connected by point contact or runner shape (thin and short separation band), or the tablet component itself However, it is in the form of a cored connection in which a core made of material such as agar that does not harm the tablet components is penetrated through the tablet.
It is a tablet that can be freely divided one by one or plural by the connected state characterized by the above.

発明の効果Effect of the invention

Ａ．例えば、同じ有効成分の錠剤で、１０ｍｍｇと、３０ｍｍｇの錠剤とでは、１０ｍｍｇの錠剤の方が安い、しかし、１０ｍｍｇを三錠にし、３０ｍｍｇとすると、３０ｍｍｇ一錠の方が安い。つまり、有効成分の量より、一錠を作るコストが高いことになる。そこで、同じ有効成分で、一個一個が連結されている状態でそこから必要な個数だけを分割できるような錠剤を作ることにより、３０ｍｍｇの錠剤が必要なくなり、小種類大量生産が可能になり、コスト低下につながる。
Ｂ また、錠剤を入荷する薬局、病院は、在庫の種類が減ることにより、不良在庫及び入荷種類の減量、管理費等の費用が減り、コストダウンが可能になる。また、小種類大量仕入れで、コストダウンが図れる。
Ｃ．服用する際は、同じ病気の軽症者は、錠剤１０ｍｍｇ一錠飲むとする。その一方で、重傷者は３０ｍｍｇ飲む場合と仮定すると、本発明の錠剤を、軽症者は、１０ｍｍｇを一錠服用し、重傷者は、１０ｍｍｇを三錠だけ分割して服用すれば良い。つまり、同じ成分の同じ容量の錠剤を飲む数を加減することで、同じ有効成分の薬は一種類用意するだけで済ます事が出来る。よって何種類も用意する必要がなくなり、多種類生産から小種類大量生産が可能になり、上記の理由を含め総合的にコストを抑えることができる。
Ｃ．従来の錠剤は、素手で割ることが困難なことが多いが、点接触、又は、ランナー状、又は、クロス型点接触、あるいは芯入り連結の形になっているので素手で折ることができる。
Ｄ．また、図８のようなクロス型点接触の場合は、ねじる動作でも少ない力で分割することが出きる。A. For example, if the tablets of the same active ingredient are 10 mmg and 30 mmg, 10 mmg tablets are cheaper, but if 10 mmg is divided into 3 tablets and 30 mmg, 30 mmg one tablet is cheaper. That is, the cost of making one tablet is higher than the amount of the active ingredient. Therefore, by making tablets that can be divided into only the required number from the same active ingredient with the same active ingredients, 30mm tablets are no longer needed, enabling small-scale mass production and cost reduction. Leading to a decline.
B In addition, pharmacies and hospitals that receive tablets can reduce costs by reducing the types of inventory, reducing the amount of defective inventory and types of goods received, and administrative costs. In addition, cost reduction can be achieved by purchasing large quantities of small types.
C. When taking, mild patients with the same illness should take a tablet of 10 mmg. On the other hand, if it is assumed that a seriously injured person drinks 30 mmg, the mildly injured person may take one tablet of 10 mmg, and a severely injured person may take 10 mmg by dividing it into three tablets. In other words, by adjusting the number of tablets with the same ingredients and the same volume, you can only prepare one kind of medicine with the same active ingredient. Therefore, it is not necessary to prepare many types, and from multi-type production to small-scale mass production is possible, and the cost can be suppressed comprehensively including the above reasons.
C. Conventional tablets are often difficult to break with bare hands, but can be folded with bare hands because they are in point contact, runner-like, cross-type point contact, or cored connection.
D. Further, in the case of the cross-type point contact as shown in FIG. 8, it is possible to divide with a small force even in a twisting operation.

本発明において、錠剤を立てた状態で、連結された形の側面図In the present invention, the side view of the connected form in the state where the tablet is erected 本発明において、錠剤の一個一個を立て並べた状態でランナー状（細く短い）に連結された形の側面図In this invention, the side view of the form connected with the shape of a runner (thin and short) in the state which arranged the tablet one by one in a row 本発明において、図１図２の斜視図1 is a perspective view of FIG. 本発明において、錠剤を立て並べた状態で、ランナー状の別な形態で連結した状態を示す側面図In this invention, in the state which arranged the tablet side by side, the side view which shows the state connected with another form of runner shape 本発明において、別の形状の錠剤を連結した形態を示す側面図The side view which shows the form which connected the tablet of another shape in this invention. 本発明において、さらに別な形状の錠剤を連結した形態を示す側面図The side view which shows the form which connected the tablet of another shape in this invention. 図５図６の平面図5 is a plan view of FIG. 本発明において、一個一個が縦横交互にクロスした状態で連結されている実施例を示す側面図In this invention, the side view which shows the Example connected one by one in the state which cross | intersected alternately vertically and horizontally 本発明において、一個一個が立てた状態で芯入り連結の実施例を示す断面図In this invention, sectional drawing which shows the Example of a cored connection in the state where each one stood up 本発明において、図４におけるランナー状にかえて、芯入り連結にした実施例を示す断面図In this invention, it replaces with the runner shape in FIG. 4, and sectional drawing which shows the Example made into the connection with a core. 本発明において、図６の点接触連結を芯入り連結にした実施例を示す断面図Sectional drawing which shows the Example which made the point contact connection of FIG. 6 the core connection in this invention. 本発明において、図８の点接触連結を芯入り連結にした実施例を示す断面図Sectional drawing which shows the Example which made the point contact connection of FIG. 8 the core connection in this invention.

以下、本発明の実施形態を説明する。
（イ）同じ成分同じ容量の有効成分で構成された錠剤（１）を立て並べ形態に連結し、点接触（２）の箇所を均等に施す。
（ロ）または、錠剤の中央付近にランナー状（３）を均等に施す。
（ハ）または、錠剤の片側辺に、ランナー状（３）の個所を均等に施す。
（ニ）または、錠剤を、図５図６のように寝かせ並べ形態で、点接触（２）を片面、又は、両面に均等に施す。
（ホ）一個一個が縦横交互にクロスしてつながったクロス型点接触（４）、又は、ランナー状（３）で、連なっている錠剤の形態は図８に示されている。
（ヘ）錠剤（１）に、寒天などの芯入り連結（５）の形態は、図９図１０図１１図１２によって示されている。
本発明は以上のような構造である。
本発明を使用する際は、必要な錠数の個所で、錠剤の端を、押す、引く、ひねる等、力を加えると、連結部で折れる。必用な錠数の如何にかかわらず、必要な錠数の箇所で連結部が分離する。
例えば、同じ有効成分の錠剤で、１０ｍｍｇと、３０ｍｍｇの錠剤とでは、１０ｍｍｇの錠剤の方が安い。しかし、１０ｍｍｇを三錠にし、３０ｍｍｇとすると、３０ｍｍｇ一錠の方が安い、つまり、有効成分の量より、一錠を作るコストが高いことになる。そこで、同じ有効成分で、一個一個が連結されている状態でそこから必要な個数だけを分割できるような錠剤を作ることにより、３０ｍｍｇの錠剤が必要なくなり、小種類大量生産が可能になり、コスト低下につながる。Embodiments of the present invention will be described below.
(I) Same component The tablets (1) composed of the same amount of active ingredients are connected in a side-by-side configuration, and the points of point contact (2) are evenly applied.
(B) Or, a runner shape (3) is applied evenly around the center of the tablet.
(C) Or, the runner-like (3) portion is evenly applied to one side of the tablet.
(D) Or, the tablets are placed side by side as shown in FIG. 5 and FIG. 6, and the point contact (2) is applied equally to one side or both sides.
(E) Cross-type point contact (4) in which each piece is crossed and connected alternately vertically and horizontally, or in the form of a runner (3), the form of the connected tablets is shown in FIG.
(F) The form of the cored connection (5) such as agar to the tablet (1) is shown by FIG. 9, FIG. 11, FIG.
The present invention has the above structure.
When using the present invention, if a force such as pushing, pulling, and twisting is applied to the end of the tablet at the required number of tablets, it will break at the connecting portion. Regardless of the required number of locks, the connecting portion is separated at the required number of locks.
For example, for tablets of the same active ingredient, 10 mmg tablets are cheaper than 10 mmg tablets. However, if 10 mmg is made into 3 tablets and 30 mmg, 30 mmg one tablet is cheaper, that is, the cost of making one tablet is higher than the amount of the active ingredient. Therefore, by making tablets that can be divided into only the required number from the same active ingredient with the same active ingredients, 30mm tablets are no longer needed, enabling small-scale mass production and cost reduction. Leading to a decline.

１．錠剤 ２．点接触 ３．ランナー状 ４．クロス型点接触 ５．芯入り連結1. Tablet 2. Point contact Runner shape 4. Cross type point contact Core connection

Claims (1)

パッケージされる前の裸の段階において、一個一個の錠剤の形は様々であっても、一個一個が点接触、又は、ランナー状（細く短い分離帯）で連結されており、又は、錠剤成分そのものではないが、錠剤成分を害しない寒天等の素材で出来た芯を錠剤に貫通させた芯入り連結の形になっていることを、特徴とする連結状態で、一個ずつ又は複数個ずつ自由に分割できる錠剤。  Even if the shape of each tablet is various in the naked stage before packaging, each tablet is connected by point contact or runner shape (thin and short separation band), or the tablet component itself However, it is in the form of a cored connection in which a core made of agar or other material that does not harm the tablet components is penetrated through the tablet, and can be freely used one by one or multiple in a characteristic connected state. A tablet that can be divided.

Images